- Home
- SRG vs KOD Comparison
SRG vs KOD Comparison
Compare SRG & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRG
- KOD
- Stock Information
- Founded
- SRG 2014
- KOD 2009
- Country
- SRG United States
- KOD United States
- Employees
- SRG N/A
- KOD N/A
- Industry
- SRG Real Estate Investment Trusts
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SRG Real Estate
- KOD Health Care
- Exchange
- SRG Nasdaq
- KOD Nasdaq
- Market Cap
- SRG 206.7M
- KOD 198.4M
- IPO Year
- SRG 2015
- KOD 2018
- Fundamental
- Price
- SRG $3.81
- KOD $9.99
- Analyst Decision
- SRG
- KOD Hold
- Analyst Count
- SRG 0
- KOD 4
- Target Price
- SRG N/A
- KOD $11.75
- AVG Volume (30 Days)
- SRG 129.3K
- KOD 673.8K
- Earning Date
- SRG 08-14-2025
- KOD 08-13-2025
- Dividend Yield
- SRG N/A
- KOD N/A
- EPS Growth
- SRG N/A
- KOD N/A
- EPS
- SRG N/A
- KOD N/A
- Revenue
- SRG $15,346,000.00
- KOD N/A
- Revenue This Year
- SRG N/A
- KOD N/A
- Revenue Next Year
- SRG N/A
- KOD N/A
- P/E Ratio
- SRG N/A
- KOD N/A
- Revenue Growth
- SRG N/A
- KOD N/A
- 52 Week Low
- SRG $2.43
- KOD $1.92
- 52 Week High
- SRG $4.77
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- SRG 69.40
- KOD 60.34
- Support Level
- SRG $3.61
- KOD $8.29
- Resistance Level
- SRG $3.74
- KOD $9.23
- Average True Range (ATR)
- SRG 0.13
- KOD 0.90
- MACD
- SRG 0.02
- KOD -0.11
- Stochastic Oscillator
- SRG 87.34
- KOD 64.46
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management, and leasing of diversified and mixed-use properties throughout the United States.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.